Analysis of 4 children with DYNC1H1 gene related spinal muscular atrophy with lower extremity predominant 1.
10.3760/cma.j.cn112140-20220714-00646
- Author:
Chang Jian YANG
1
;
Shuang WANG
1
;
Dan Dan TAN
1
;
Yi Dan LIU
1
;
Yan Bin FAN
1
;
Cui Jie WEI
1
;
Dan Yu SONG
1
;
Ying ZHU
2
;
Hui XIONG
1
Author Information
1. Department of Pediatrics, Peking University First Hospital, Beijing 100034, China.
2. Department of Medical Imaging, Peking University First Hospital, Beijing 100034, China.
- Publication Type:Journal Article
- MeSH:
Female;
Male;
Humans;
Intellectual Disability;
Retrospective Studies;
Muscular Atrophy, Spinal/genetics*;
Lower Extremity;
Muscle Weakness;
Muscular Atrophy;
Contracture;
Cytoplasmic Dyneins/genetics*
- From:
Chinese Journal of Pediatrics
2023;61(2):154-158
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To investigate the clinical features and gene variation characteristics of children with dynein cytoplasmic 1 heavy chain 1 (DYNC1H1) gene associated spinal muscular atrophy with lower extremity predominant (SMALED) 1. Methods: The clinical data of 4 SMALED1 children admitted to Peking University First Hospital from December 2018 to May 2021, who were found to have pathogenic variation of DYNC1H1 gene through genetic testing, except for other genes known to be related to motor retardation, were retrospectively summarized to analyze the phenotype and genotype characteristics. Results: There were 3 males and 1 female. The age of onset was 1 year, 1 day, 1 day and 4 months, respectively. The age of diagnosis was 4 years and 10 months, 9 months, 5 years and 9 months, and 3 years and 1 month, respectively. The clinical manifestations were muscle weakness and muscular atrophy of lower limbs, 2 cases with foot deformity, 1 case with early non progressive joint contracture, 1 case with hip dislocation and 1 case with mental retardation. De novo heterozygous missense variations in DYNC1H1 gene were found in all 4 children. According to the rating of American College of medical genetics and genomics, they were all possible pathogenic and pathogenic variations, with p.R598C, p.P776L, p.Y1109D variations had been reported, and p.I1086R variation had not been reported. Conclusions: For those with unexplained lower limb muscle weakness, muscle atrophy, joint contracture and foot deformity, upper limb motor ability related retention, with or without mental retardation, as well as the motor ability progresses slowly, it is necessary to consider the possibility of SMALED1 and the detection of DYNC1H1 gene when necessary.
